Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v13-EN | Version v6-FR | |
|---|---|---|
| Language | English | French |
| Date Updated | 2018-03-23 | 2018-03-16 |
| Drug Identification Number | 00755575 | 00755575 |
| Brand name | MODECATE CONCENTRATE | MODECATE CONCENTRATE |
| Common or Proper name | Fluphenazine Decanoate | Fluphenazine Decanoate |
| Company Name | BRISTOL-MYERS SQUIBB CANADA | BRISTOL-MYERS SQUIBB CANADA |
| Ingredients | FLUPHENAZINE DECANOATE | FLUPHENAZINE DECANOATE |
| Strength(s) | 100MG | 100MG |
| Dosage form(s) | LIQUID | LIQUID |
| Route of administration | INTRAMUSCULAR SUBCUTANEOUS | INTRAMUSCULAR SUBCUTANEOUS |
| Packaging size | 5 amp x 1ml | 5 amp x 1ml |
| ATC code | N05AB | N05AB |
| ATC description | ANTIPSYCHOTICS | ANTIPSYCHOTICS |
| Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
| Anticipated start date | 2018-03-22 | 2018-03-22 |
| Actual start date | ||
| Estimated end date | 2018-03-23 | |
| Actual end date | 2018-03-22 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Stock available as of March 22nd. | We are currently allocating stock to ensure we avoid a stock out. New lot due tentative mid-March 2018. |
| Health Canada comments |